PG
BLUE

PEAK6 Group’s bluebird bio BLUE Stock Holding History

PEAK6 Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-120
Closed -$277K – 4337
2017
Q4 		$277K Buy
+120
New +$244K ﹤0.01% 2940
2015
Q4 		– Sell
-656
Closed -$727K – 4755
2015
Q3 		$727K Buy
+656
New +$1.2M ﹤0.01% 2530

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

PEAK6 Group's BLUE Position: Q1 2018 in Review

PEAK6 Group sold out of bluebird bio (BLUE) in Q1 2018, closing a stake of 120 shares — an estimated $277K sold.

PEAK6 Group first reported a position in BLUE in Q3 2015 and held it in 2 quarters. The position peaked at $727K in Q3 2015. 303 funds tracked by Wall St. Rank hold BLUE as of Q1 2018.

  • PEAK6 Group reported no remaining bluebird bio position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 120 bluebird bio shares in Q1 2018, an estimated $277K.
  • PEAK6 Group first reported a position in bluebird bio in Q3 2015 and held it in 2 quarters.
  • PEAK6 Group's bluebird bio position peaked at $727K in Q3 2015.
  • 303 funds tracked by Wall St. Rank held bluebird bio as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.